TW200833374A - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- TW200833374A TW200833374A TW096142176A TW96142176A TW200833374A TW 200833374 A TW200833374 A TW 200833374A TW 096142176 A TW096142176 A TW 096142176A TW 96142176 A TW96142176 A TW 96142176A TW 200833374 A TW200833374 A TW 200833374A
- Authority
- TW
- Taiwan
- Prior art keywords
- pharmaceutical composition
- isoindoline
- pentamethyl
- absorbability
- benzofuran
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006303800 | 2006-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200833374A true TW200833374A (en) | 2008-08-16 |
Family
ID=38942774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW096142176A TW200833374A (en) | 2006-11-09 | 2007-11-08 | Pharmaceutical composition |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100273852A1 (zh) |
EP (1) | EP2079455B1 (zh) |
JP (1) | JP2010509188A (zh) |
AR (1) | AR063618A1 (zh) |
AT (1) | ATE456365T1 (zh) |
CA (1) | CA2668864A1 (zh) |
CL (1) | CL2007003217A1 (zh) |
DE (1) | DE602007004642D1 (zh) |
PE (1) | PE20081491A1 (zh) |
TW (1) | TW200833374A (zh) |
WO (1) | WO2008056822A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6982870B2 (ja) * | 2015-05-06 | 2021-12-17 | シンアジャル コーポレイション | 薬物粒子を含有する医薬懸濁液、それらの投与のためのデバイス、およびそれらの使用方法 |
JP7492917B2 (ja) | 2018-02-09 | 2024-05-30 | デシベル セラピューティクス インコーポレイテッド | 抗白金化学保護剤を含む高張医薬組成物 |
US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
ATE261435T1 (de) * | 1998-12-04 | 2004-03-15 | Takeda Chemical Industries Ltd | Benzofuranderivate, verfahren zu ihrer herstellung und deren verwendungen |
CN1431896A (zh) * | 2000-04-04 | 2003-07-23 | 盐野义制药株式会社 | 含有高脂溶性药物的油性组合物 |
CA2432410A1 (en) * | 2000-12-28 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Process for preparing optically active 2,3-dihydro- benzofuran compounds |
WO2003051355A1 (fr) * | 2001-12-19 | 2003-06-26 | Takeda Chemical Industries, Ltd. | Compositions solides refermant des composes instables a l'oxygene et procede de stabilisation de ces composes |
KR101011657B1 (ko) * | 2002-03-01 | 2011-01-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 항우울제 |
-
2007
- 2007-11-08 TW TW096142176A patent/TW200833374A/zh unknown
- 2007-11-08 CL CL200703217A patent/CL2007003217A1/es unknown
- 2007-11-08 CA CA002668864A patent/CA2668864A1/en not_active Abandoned
- 2007-11-08 DE DE602007004642T patent/DE602007004642D1/de active Active
- 2007-11-08 US US12/513,847 patent/US20100273852A1/en not_active Abandoned
- 2007-11-08 AT AT07831871T patent/ATE456365T1/de not_active IP Right Cessation
- 2007-11-08 WO PCT/JP2007/072141 patent/WO2008056822A1/en active Application Filing
- 2007-11-08 EP EP07831871A patent/EP2079455B1/en not_active Not-in-force
- 2007-11-08 PE PE2007001543A patent/PE20081491A1/es not_active Application Discontinuation
- 2007-11-08 JP JP2009517780A patent/JP2010509188A/ja not_active Withdrawn
- 2007-11-08 AR ARP070104976A patent/AR063618A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2079455B1 (en) | 2010-01-27 |
US20100273852A1 (en) | 2010-10-28 |
ATE456365T1 (de) | 2010-02-15 |
CL2007003217A1 (es) | 2008-07-04 |
DE602007004642D1 (de) | 2010-03-18 |
JP2010509188A (ja) | 2010-03-25 |
WO2008056822A1 (en) | 2008-05-15 |
CA2668864A1 (en) | 2008-05-15 |
EP2079455A1 (en) | 2009-07-22 |
PE20081491A1 (es) | 2008-11-12 |
AR063618A1 (es) | 2009-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1773768B8 (en) | Pyrrole derivatives as pharmaceutical agents | |
EP2226074A3 (en) | Pharmaceutical compositions and their methods of use | |
IL192967A0 (en) | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof | |
IL189008A (en) | History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane | |
EP1783137A4 (en) | GALACTOSIS DERIVATIVE, DRUG VECTOR AND THERAPEUTIC PREPARATION | |
MX2009004766A (es) | Derivados de espiroindolinona. | |
WO2007062078A3 (en) | Thrombopoietin activity modulating compounds and methods | |
IL193024A0 (en) | Levetiracetam formulations and methods for their manufacture | |
HK1112916A1 (en) | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof 3- | |
WO2007075825A3 (en) | Lipophilic anticancer drug compounds | |
IL184895A0 (en) | Pharmaceutical compositions containing glucuronidated nebivolol metabolites | |
SG170054A1 (en) | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | |
HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
BRPI0509067A (pt) | formulações de matriz oral que compreendem licarbazepina | |
IL186062A0 (en) | Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
HUP0401523A3 (en) | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them | |
ECSP066872A (es) | Tabletas desintegrantes que comprenden licarbazepina | |
TW200833374A (en) | Pharmaceutical composition | |
EP2035406A4 (en) | NEW SUBSTITUTED 1H-CHINAZOLIN-2,4-DION DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | |
WO2010080414A3 (en) | Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents | |
WO2007025994A3 (fr) | Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant | |
UA87152C2 (ru) | Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения | |
AU2003245033A1 (en) | An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation | |
WO2009026172A3 (en) | New approach for designing diabetes drugs | |
WO2006107806A3 (en) | Stannsoporfin compositions and administration |